![]() |
![]() |
| View the Winning Photo |
![]() |
| Click Here to Preview our December Issue |
![]() |
| Anna Stashower President/Publisher Welcome to PM360 |
COMMON SENSE By Bud Bilanich |
![]() |
| Moving Mountains— or at Least a Few Boulders |
|
| HOT TOPICS | |
![]() |
U.S. STILL THE GO-TO MARKET TO UNVEIL NEW BRANDS The United States continues to lead when it comes to being the preferred market for introducing new products. |
| DRUG SALES EXPECTED TO REACH A HISTORIC LOW The U.S. pharmaceutical market will only grow 1% to 2% in 2008, marking the slowest rate on record this year. |
|
| POOR NEIGHBORHOODS SUBJECT TO MORE EXPENSIVE DRUGS A recent study revealed that pharmacies in Florida’s poorest zip codes charge more for the medications than those in richer areas of the state. |
| FEATURES | |
![]() |
It Takes a Real Value Proposition to Build Brand Loyalty By Bill Ott, MBA, and Rita E. Numerof, PhD It is paramount that pharmaceutical companies discover ways to build consumer loyalty for their brands, but creative marketing alone may not be enough in today’s market. |
![]() |
Trust Consumers and They Will Trust You in Return By Anita St. Clair Consumer trust in the pharmaceutical industry may be waning, but it’s not too late to repair this fragile relationship. Providing consumers with information and education so they can better understand their conditions and treatment options will help them regain trust in the industry and its products. |
![]() |
Journal Readership: Has Physician Behavior Changed? By Tom St. Peter The medical journal has been a staple of information for physicians, but with Web-based services easily accessible, is journal readership still strong? |
![]() |
The Commercial Fate of Orphan Drugs By Safia Abouelleil and Albert Wertheimer, PhD, MBA Many pharmaceutical companies frown on releasing an orphan drug due to fears of poor returns on investment. However, this article details the reasons why orphan drugs are important and how they can potentially benefit companies. |
| IN THIS ISSUE |
| GUEST COMMENTARY - Promote or Perish: The Pharmaceutical Sales Model Needs Innovation Now Quang X. Pham HEALTHCARE HIGHLIGHTS - Poor Neighborhoods Subject to More Expensive Drugs; Drug Research Faces Setbacks in the Current Economy FDA UPDATE - Reducing Overactive Bladder Urges; New Formulation for Electrolyte Disorder; More Options for Treatment “Wear Off” INDUSTRY BRIEFS - Interactive Patient Tools; New European Division; Extortion Threats E-SOURCE - Nonpersonal Promotional Programs: They’re a New Incentive for Your Salesforce Rob Likoff LIFESTYLE - Reduce Your Carbon Footprint; Keeping Warm and Paying Less COMMON SENSE Moving Mountains—or at Least a Few Boulders Bud Bilanich UNDERSTANDING THE PHYSICIAN A Day In the Life: The Daily Routine and Headaches of Physicians on the Front Line Combating Illness and Suffering Mitchell E. Stashower, MD, FAAD END-OF-LIFECYCLE STRATEGIES - Authorized Generics Ashwin Dandekar THE SCENE - eyeforpharma’s 3rd Annual eCommunication and Online Marketing Summit and 5th Annual Patient Adherence and Persistence USA Congress CALENDAR - A quick-reference list of upcoming meetings and events CUTTING EDGE - Pico Pocket Projector; LifeBook U820; BlackBerry Storm MOVERS AND SHAKERS - Movement and promotions in the industry DESTINATIONS - Toledo, BELIZE -- Down and Dirty PHOTO FINISH - Night Petal |
Site (c) 2008 AMS Group LLC.
